BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8604573)

  • 1. Assessing the costs and benefits of alternative rescreening strategies.
    Hutchinson ML
    Acta Cytol; 1996; 40(1):4-8. PubMed ID: 8604573
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs and benefits of alternative rescreening strategies.
    Schechter CB
    Acta Cytol; 1996; 40(5):1111-4. PubMed ID: 8842186
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing costs and benefits of PAPNET.
    Boon ME
    Acta Cytol; 1996; 40(5):1109-11. PubMed ID: 8842185
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescreening of cervical Papanicolaou smears using PAPNET.
    Schechter CB
    JAMA; 1998 Jun; 279(22):1787; author reply 1787-8. PubMed ID: 9628708
    [No Abstract]   [Full Text] [Related]  

  • 5. Rescreening of cervical Papanicolaou smears using PAPNET.
    Mango LJ; Radensky PW
    JAMA; 1998 Jun; 279(22):1786-7; author reply 1787-8. PubMed ID: 9628707
    [No Abstract]   [Full Text] [Related]  

  • 6. The utility and cost-effectiveness of Pap test rescreening.
    Raab SS
    Clin Lab Manage Rev; 1998; 12(2):91-6. PubMed ID: 10178714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted quality assurance.
    Wied GL; Bartels PH; Bibbo M; Gupta PK; Gurley AM; Hilgarth M; Jiménez-Ayala M; Kato H; Knight BK; McGoogan E; Medley G; Meisels A; Nishiya I; Nozawa S; Ramzy I; Reith A; Rilke F; Rivera-Pomar JM; Rosenthal DL; Schenck U; Verhest AP; Vooijs GP
    Acta Cytol; 1996; 40(1):1-3. PubMed ID: 8604561
    [No Abstract]   [Full Text] [Related]  

  • 8. Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost.
    Kaminsky FC; Benneyan JC; Mullins DL
    Acta Cytol; 1997; 41(1):209-23. PubMed ID: 9022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature.
    Broadstock M
    N Z Med J; 2001 Jul; 114(1135):311-3. PubMed ID: 11556445
    [No Abstract]   [Full Text] [Related]  

  • 10. 100% rapid (partial) rescreening for quality assurance.
    Lemay C; Meisels A
    Acta Cytol; 1999; 43(1):86-8. PubMed ID: 9987456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic model for comparing alternative policies for cervical cytologic smear screening.
    Kaminsky FC; Burke RJ; Haberle KR; Mullins DL
    Acta Cytol; 1995; 39(2):232-8. PubMed ID: 7887070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
    Halford JA; Wright RG; Ditchmen EJ
    Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears.
    McQuarrie HG; Ogden J; Costa M
    J Reprod Med; 2000 Nov; 45(11):898-906. PubMed ID: 11127101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roche Image Analysis Systems, Inc.
    Knesel EA
    Acta Cytol; 1996; 40(1):60-6. PubMed ID: 8604576
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromedical Systems, Inc.
    Mango LJ
    Acta Cytol; 1996; 40(1):53-9. PubMed ID: 8604575
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cervical smears. Contribution of automated screening].
    Ziol M; Vacher-Lavenu MC
    Ann Pathol; 1996 Nov; 16(5):351-5. PubMed ID: 9004722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The PAPNET system in cytological rescreening of cervical smears].
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System.
    Patten SF; Lee JS; Nelson AC
    Acta Cytol; 1996; 40(1):45-52. PubMed ID: 8604574
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.